Challenging the 50‐50 rule for the basal‐bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic control

BACKGROUND: For patients using basal‐bolus insulin therapy, it is widespread clinical practice to aim for a 50‐50 ratio between basal and total daily bolus. However, this practice was based on a small study of individuals without diabetes. To assess the rule in real‐world practice, we retrospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Harper, Roy, Bashan, Eran, Williams, Kevin J., Sritharan, Sajitha, Willis, Mark, Marriott, Deanna J., Hodish, Israel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107921/
https://www.ncbi.nlm.nih.gov/pubmed/36309953
http://dx.doi.org/10.1111/dom.14904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107921/
https://www.ncbi.nlm.nih.gov/pubmed/36309953
http://dx.doi.org/10.1111/dom.14904

Ejemplares similares